OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Extracellular vesicle-based checkpoint regulation and immune state in cancer
Keywan Mortezaee, Jamal Majidpoor
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 10
Keywan Mortezaee, Jamal Majidpoor
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 10
Showing 10 citing articles:
Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
Vinith Johnson, Sunil Vasu, Uday Kumar Sukumar, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 32
Vinith Johnson, Sunil Vasu, Uday Kumar Sukumar, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 32
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110032-110032
Closed Access | Times Cited: 16
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110032-110032
Closed Access | Times Cited: 16
Extracellular vesicle-mediated communication between CD8+ cytotoxic T cells and tumor cells
Zeyu Huang, Xuehui Liu, Qinghao Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Zeyu Huang, Xuehui Liu, Qinghao Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors
Ting Yan, Yu Lun, Dangang Shangguan, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109638-109638
Open Access | Times Cited: 21
Ting Yan, Yu Lun, Dangang Shangguan, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109638-109638
Open Access | Times Cited: 21
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Anti-PD-(L)1 therapy of non-small cell lung cancer–A summary of clinical trials and current progresses
Keywan Mortezaee, Jamal Majidpoor
Heliyon (2023) Vol. 9, Iss. 3, pp. e14566-e14566
Open Access | Times Cited: 7
Keywan Mortezaee, Jamal Majidpoor
Heliyon (2023) Vol. 9, Iss. 3, pp. e14566-e14566
Open Access | Times Cited: 7
The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114436-114436
Open Access | Times Cited: 4
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114436-114436
Open Access | Times Cited: 4
Reinstating immunogenicity using bispecific anti-checkpoint/agent inhibitors
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114621-114621
Open Access | Times Cited: 4
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114621-114621
Open Access | Times Cited: 4
Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma
Wei Xu, Yang Chen, Zhi Zhang, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 3
Wei Xu, Yang Chen, Zhi Zhang, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 3
Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
Jamal Majidpoor, Fardin Fathi, Keywan Mortezaee
Deleted Journal (2023) Vol. 28, Iss. 4, pp. 160-173
Open Access
Jamal Majidpoor, Fardin Fathi, Keywan Mortezaee
Deleted Journal (2023) Vol. 28, Iss. 4, pp. 160-173
Open Access
